FHIR IG analytics| Package | lt.hl7.fhir.prostate |
| Resource Type | Questionnaire |
| Id | Questionnaire-questionnaire-prostate-pathology-espbi.json |
| FHIR Version | R5 |
| Source | https://build.fhir.org/ig/HL7LT/ig-lt-prostate/Questionnaire-questionnaire-prostate-pathology-espbi.html |
| URL | https://hl7.lt/fhir/prostate/Questionnaire/prostate-pathology-espbi |
| Version | 0.1.0 |
| Status | draft |
| Date | 2025-03-24 |
| Name | ProstatePathologyEspbi |
| Title | Prostate pathology structured report |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
English
Generated Narrative: Questionnaire questionnaire-prostate-pathology-espbi
Language: en
| LinkID | Text | Cardinality | Type | Description & Constraints |
|---|---|---|---|---|
  ProstatePathologyEspbi | Questionnaire | https://hl7.lt/fhir/prostate/Questionnaire/prostate-pathology-espbi#0.1.0 | ||
  grp-specimen | Specimen and macroscopic context | 0..1 | group | |
  bioptate-length-mm | Bioptate length (mm) | 0..1 | quantity | |
  specimen-quality | Quality of materials | 0..1 | coding | Options: 3 options |
| grp-treatment-effect | Treatment effect (selected) | 0..1 | group | |
| treatment-effect | Treatment effect on tumour | 0..1 | coding | Options: 5 options |
| grp-histology | Histological tumour type | 0..1 | group | |
| histological-type | Primary histological type | 0..1 | coding | Options: 16 options |
 histological-comment | Histological type comment | 0..1 | text | |
| grp-grade | Grade (ISUP) | 0..1 | group | |
| isup-grade-group | International Society of Urological Pathology grade group | 0..1 | coding | Options: 5 options |
| grp-idc-cribriform | IDC and cribriform | 0..1 | group | |
| idc-status | Intraductal carcinoma (IDC) | 0..1 | coding | Options: 2 options |
| cribriform-status | Cribriform glands | 0..1 | coding | Options: 3 options |
| grp-additional-grade-burden | Additional grade and tumour burden (subset) | 0..1 | group | |
| pattern4-pct-band | Quantity of Pattern 4 (percent band) | 0..1 | coding | Options: 4 options |
| tumor-percent-in-biopsy | Tumour percentage in biopsy tissue | 0..1 | coding | Options: 4 options |
| grp-invasion | Local invasion (subset) | 0..1 | group | |
 periprostatic-fat-invasion | Tumour infiltration in periprostatic adipose tissue | 0..1 | coding | Options: 3 options |
| perineural-invasion | Perineural invasion | 0..1 | coding | Options: 4 options |
| perineural-invasion-notes | Perineural invasion notes | 0..1 | text | |
| lymphovascular-invasion | Lymphatic and/or vascular tumour invasion | 0..1 | coding | Options: 4 options |
| lymphovascular-invasion-notes | Lymphovascular invasion notes | 0..1 | text | |
| Documentation for this format | ||||
Options Sets
Answer options for specimen-quality
Answer options for treatment-effect
Answer options for histological-type
Answer options for isup-grade-group
Answer options for idc-status
Answer options for cribriform-status
Answer options for pattern4-pct-band
Answer options for tumor-percent-in-biopsy
Answer options for periprostatic-fat-invasion
Answer options for perineural-invasion
Answer options for lymphovascular-invasion
Lithuanian
Generated Narrative: Questionnaire questionnaire-prostate-pathology-espbi
Language: en
| LinkID | Text | Cardinality | Type | Description & Constraints |
|---|---|---|---|---|
| ProstatePathologyEspbi | Questionnaire | https://hl7.lt/fhir/prostate/Questionnaire/prostate-pathology-espbi#0.1.0 | ||
| grp-specimen | Specimen and macroscopic context | 0..1 | group | |
| bioptate-length-mm | Bioptate length (mm) | 0..1 | quantity | |
| specimen-quality | Quality of materials | 0..1 | coding | Options: 3 options |
| grp-treatment-effect | Treatment effect (selected) | 0..1 | group | |
| treatment-effect | Treatment effect on tumour | 0..1 | coding | Options: 5 options |
| grp-histology | Histological tumour type | 0..1 | group | |
| histological-type | Primary histological type | 0..1 | coding | Options: 16 options |
| histological-comment | Histological type comment | 0..1 | text | |
| grp-grade | Grade (ISUP) | 0..1 | group | |
| isup-grade-group | International Society of Urological Pathology grade group | 0..1 | coding | Options: 5 options |
| grp-idc-cribriform | IDC and cribriform | 0..1 | group | |
| idc-status | Intraductal carcinoma (IDC) | 0..1 | coding | Options: 2 options |
| cribriform-status | Cribriform glands | 0..1 | coding | Options: 3 options |
| grp-additional-grade-burden | Additional grade and tumour burden (subset) | 0..1 | group | |
| pattern4-pct-band | Quantity of Pattern 4 (percent band) | 0..1 | coding | Options: 4 options |
| tumor-percent-in-biopsy | Tumour percentage in biopsy tissue | 0..1 | coding | Options: 4 options |
| grp-invasion | Local invasion (subset) | 0..1 | group | |
| periprostatic-fat-invasion | Tumour infiltration in periprostatic adipose tissue | 0..1 | coding | Options: 3 options |
| perineural-invasion | Perineural invasion | 0..1 | coding | Options: 4 options |
| perineural-invasion-notes | Perineural invasion notes | 0..1 | text | |
| lymphovascular-invasion | Lymphatic and/or vascular tumour invasion | 0..1 | coding | Options: 4 options |
| lymphovascular-invasion-notes | Lymphovascular invasion notes | 0..1 | text | |
| Documentation for this format | ||||
Options Sets
Answer options for specimen-quality
Answer options for treatment-effect
Answer options for histological-type
Answer options for isup-grade-group
Answer options for idc-status
Answer options for cribriform-status
Answer options for pattern4-pct-band
Answer options for tumor-percent-in-biopsy
Answer options for periprostatic-fat-invasion
Answer options for perineural-invasion
Answer options for lymphovascular-invasion
FHIR
FHIRsmith{
"resourceType": "Questionnaire",
"id": "questionnaire-prostate-pathology-espbi",
"language": "en",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://hl7.lt/fhir/prostate/Questionnaire/prostate-pathology-espbi",
"version": "0.1.0",
"name": "ProstatePathologyEspbi",
"title": "Prostate pathology structured report",
"status": "draft",
"subjectType": [
"Patient"
],
"date": "2025-03-24",
"publisher": "Lithuanian Medical Library",
"contact": [
{
"name": "Lithuanian Medical Library",
"telecom": [
{
"system": "url",
"value": "https://medicinosnk.lt"
},
{
"system": "email",
"value": "info@medicinosnk.lt"
}
]
}
],
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "LT"
}
]
}
],
"item": [
{
"linkId": "grp-specimen",
"text": "Specimen and macroscopic context",
"type": "group",
"item": [
{
"linkId": "bioptate-length-mm",
"text": "Bioptate length (mm)",
"type": "quantity"
},
{
"linkId": "specimen-quality",
"text": "Quality of materials",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "specimen-satisfactory",
"display": "Specimen satisfactory for evaluation"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "specimen-limited",
"display": "Specimen satisfactory but limited"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "specimen-insufficient",
"display": "Insufficient tissue for diagnosis"
}
}
]
}
]
},
{
"linkId": "grp-treatment-effect",
"text": "Treatment effect (selected)",
"type": "group",
"item": [
{
"linkId": "treatment-effect",
"text": "Treatment effect on tumour",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "treatment-unknown",
"display": "Treatment effect unknown"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "treatment-unidentifiable",
"display": "Treatment effect unidentifiable"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "treatment-radiotherapy",
"display": "Observed radiotherapy effect"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "treatment-hormone",
"display": "Observed hormone therapy effect"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "treatment-other",
"display": "Observed other therapy effect"
}
}
]
}
]
},
{
"linkId": "grp-histology",
"text": "Histological tumour type",
"type": "group",
"item": [
{
"linkId": "histological-type",
"text": "Primary histological type",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-acinar",
"display": "Acinar adenocarcinoma (conventional)"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-acinar-signet-ring",
"display": "Acinar adenocarcinoma, signet-ring cell-like"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-acinar-pleomorphic",
"display": "Acinar adenocarcinoma, pleomorphic giant cell"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-acinar-sarcomatoid",
"display": "Acinar adenocarcinoma, sarcomatoid"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-acinar-pin-like",
"display": "Acinar adenocarcinoma, PIN-like"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-idc-isolated",
"display": "Isolated intraductal carcinoma"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-ductal",
"display": "Ductal adenocarcinoma"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-adenosquamous",
"display": "Adenosquamous carcinoma"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-squamous",
"display": "Squamous cell carcinoma"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-basal-cell",
"display": "Basal cell (adenoid cystic) carcinoma"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-neuro-adeno",
"display": "Adenocarcinoma with neuroendocrine differentiation"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-neuro-well-diff",
"display": "Well-differentiated neuroendocrine tumor"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-neuro-small-cell",
"display": "Small cell neuroendocrine carcinoma"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-neuro-large-cell",
"display": "Large cell neuroendocrine carcinoma"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-unassessable",
"display": "Carcinoma, type unassessable"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-other",
"display": "Other histological type (see comment)"
}
}
]
},
{
"linkId": "histological-comment",
"text": "Histological type comment",
"type": "text"
}
]
},
{
"linkId": "grp-grade",
"text": "Grade (ISUP)",
"type": "group",
"item": [
{
"linkId": "isup-grade-group",
"text": "International Society of Urological Pathology grade group",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "isup-gg1",
"display": "ISUP Grade Group 1 (Gleason 3+3)"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "isup-gg2",
"display": "ISUP Grade Group 2 (Gleason 3+4)"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "isup-gg3",
"display": "ISUP Grade Group 3 (Gleason 4+3)"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "isup-gg4",
"display": "ISUP Grade Group 4 (Gleason 4+4 or equivalent)"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "isup-gg5",
"display": "ISUP Grade Group 5 (Gleason 4+5 / 5+4 / 5+5)"
}
}
]
}
]
},
{
"linkId": "grp-idc-cribriform",
"text": "IDC and cribriform",
"type": "group",
"item": [
{
"linkId": "idc-status",
"text": "Intraductal carcinoma (IDC)",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "idc-absent",
"display": "Intraductal carcinoma not identified"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "idc-present",
"display": "Intraductal carcinoma identifiable"
}
}
]
},
{
"linkId": "cribriform-status",
"text": "Cribriform glands",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "cribriform-na",
"display": "Cribriform not applicable"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "cribriform-unknown",
"display": "Cribriform undefined"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "cribriform-present",
"display": "Cribriform identifiable"
}
}
]
}
]
},
{
"linkId": "grp-additional-grade-burden",
"text": "Additional grade and tumour burden (subset)",
"type": "group",
"item": [
{
"linkId": "pattern4-pct-band",
"text": "Quantity of Pattern 4 (percent band)",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "pattern4-pct-na",
"display": "Pattern 4 %: not applicable"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "pattern4-pct-lte5",
"display": "Pattern 4 %: ≤5%"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "pattern4-pct-6-10",
"display": "Pattern 4 %: 6–10%"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "pattern4-pct-gt40",
"display": "Pattern 4 %: >40%"
}
}
]
},
{
"linkId": "tumor-percent-in-biopsy",
"text": "Tumour percentage in biopsy tissue",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "tumor-pct-lt1",
"display": "Tumour % in biopsy: <1%"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "tumor-pct-1-5",
"display": "Tumour % in biopsy: 1–5%"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "tumor-pct-gt90",
"display": "Tumour % in biopsy: >90%"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "tumor-pct-uneval",
"display": "Tumour %: cannot be evaluated"
}
}
]
}
]
},
{
"linkId": "grp-invasion",
"text": "Local invasion (subset)",
"type": "group",
"item": [
{
"linkId": "periprostatic-fat-invasion",
"text": "Tumour infiltration in periprostatic adipose tissue",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "periprostatic-unknown",
"display": "Periprostatic fat invasion: unidentifiable"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "periprostatic-absent",
"display": "Periprostatic fat invasion: not identified"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "periprostatic-present",
"display": "Periprostatic fat invasion: present"
}
}
]
},
{
"linkId": "perineural-invasion",
"text": "Perineural invasion",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "perineural-absent",
"display": "Perineural invasion not identified"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "perineural-present",
"display": "Perineural invasion present"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "perineural-ambiguous",
"display": "Perineural invasion ambiguous"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "perineural-uneval",
"display": "Perineural invasion cannot be evaluated"
}
}
]
},
{
"linkId": "perineural-invasion-notes",
"text": "Perineural invasion notes",
"type": "text"
},
{
"linkId": "lymphovascular-invasion",
"text": "Lymphatic and/or vascular tumour invasion",
"type": "coding",
"answerOption": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "lymphovascular-absent",
"display": "Lymphovascular invasion unidentifiable / not available"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "lymphovascular-present",
"display": "Lymphovascular invasion identifiable"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "lymphovascular-ambiguous",
"display": "Lymphovascular invasion ambiguous"
}
},
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "lymphovascular-uneval",
"display": "Lymphovascular invasion cannot be evaluated"
}
}
]
},
{
"linkId": "lymphovascular-invasion-notes",
"text": "Lymphovascular invasion notes",
"type": "text"
}
]
}
]
}